Sonova Holding (OTCMKTS:SONVY - Get Free Report) was the target of a large drop in short interest in the month of September. As of September 30th, there was short interest totaling 2,700 shares, a drop of 92.1% from the September 15th total of 34,300 shares. Based on an average daily volume of 144,700 shares, the days-to-cover ratio is currently 0.0 days. Based on an average daily volume of 144,700 shares, the days-to-cover ratio is currently 0.0 days.
Analyst Ratings Changes
A number of equities analysts recently weighed in on SONVY shares. Rothschild Redb upgraded Sonova from a "strong sell" rating to a "hold" rating in a research report on Monday, October 6th. Sanford C. Bernstein upgraded Sonova from a "hold" rating to a "strong-buy" rating in a research report on Friday, July 18th. Zacks Research upgraded Sonova from a "strong sell" rating to a "hold" rating in a research report on Thursday, August 28th. Finally, Barclays downgraded Sonova from a "hold" rating to a "strong sell" rating in a research note on Friday, June 20th. One research analyst has rated the stock with a Strong Buy rating, five have issued a Hold rating and four have issued a Sell rating to the stock. Based on data from MarketBeat, the company has a consensus rating of "Reduce".
View Our Latest Stock Analysis on Sonova
Sonova Stock Performance
Sonova stock traded up $0.23 during mid-day trading on Thursday, hitting $54.68. The company's stock had a trading volume of 36,650 shares, compared to its average volume of 26,275. The firm's 50 day moving average is $57.06 and its 200 day moving average is $58.86. The company has a quick ratio of 0.96, a current ratio of 1.27 and a debt-to-equity ratio of 0.45. Sonova has a 52-week low of $52.83 and a 52-week high of $77.56.
About Sonova
(
Get Free Report)
Sonova Holding AG manufactures and sells hearing care solutions for adults and children in the United States, Europe, the Middle East, Africa, and the Asia Pacific. It operates through two segments, Hearing Instruments and Cochlear Implants segments. The Hearing Instruments segments engages in the design, development, manufacture, distribution, and service of hearing instruments and related products, as well as wireless headsets, speech-enhanced hearables, and audiophile headphones under the Phonak, Unitron, Hansaton, and Sennheiser brand names; and audiological care services under the AudioNova, Audium, Audition Santé, Boots Hearingcare, Connect Hearing, Geers, Hansaton, Lapperre, Schoonenberg, and Triton Hearing brands.
Further Reading
This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider SONOVA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SONOVA wasn't on the list.
While SONOVA currently has a Reduce rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.